Laguna Pharmaceuticals, Inc. Report issue

For profit Phase 3
Founded: La Jolla CA United States (2006)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2012
NCT01691313
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

ChanRx Corp.

Active Ingredients

Drugs in Phase 3 Trials (1)

vanoxerine (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 3)

Atrial Flutter (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1